Navigation Links
Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
Date:11/27/2012

SAN DIEGO, Nov. 27, 2012 /PRNewswire/ -- Fate Therapeutics, Inc., a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators, announced today the initiation of a randomized, controlled, Phase 2 multi-center study of its investigational hematopoietic stem cell therapy, ProHema, in adult patients undergoing double umbilical cord blood transplantation (dUCBT) for hematologic malignancy.  The advancement of ProHema into later-stage development builds upon positive results from a Phase 1b single-center study, interactions with the U.S. Food and Drug Administration and refinements to the product manufacturing process.  The previously completed Phase 1b study achieved its primary objective of demonstrating safety and tolerability.  The study also established early clinical proof-of-concept – trends of accelerated neutrophil recovery, improved 100-day survival and low rates of graft-versus-host disease were evident, and durable and preferential reconstitution with ProHema occurred in 10 of 12 evaluable patients.  ProHema is produced through a proprietary, two-hour, ex vivo modulation process, which has been shown to significantly activate key biological pathways involved in hematopoietic stem cell homing, proliferation and survival in preclinical models.

"Allogeneic umbilical cord blood transplantation holds great promise as a potentially curative treatment for children and adults with hematologic malignancies and many other life-threatening, non-malignant disorders," said Christian Weyer, M.D., M.A.S., President and Chief Executive Officer of Fate Therapeutics.  "ProHema is being developed with the intent to improve outcomes in patients undergoing cord blood transplantation by facilitating both accelerated engraftment and durable reconstitution using a simple, point-of-care, ex vivo modulation process. The initiation of Phase 2 marks an important milestone for the company and bri
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
2. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
3. Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
4. Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
5. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
6. Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting
7. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
8. Stemline Therapeutics Lead Clinical Candidate SL-401 Induces a Complete Response in a Patient with a Drug-Refractory Plasmacytoid Dendritic Cell Neoplasm
9. Echo Therapeutics Announces Third Quarter 2012 Financial Results
10. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
11. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 New technology in the ... allow physicians to see and assess brain tissue more ... to study authors who released their findings today at ... Annual Meeting in Colorado Springs, CO. ... field of neurointervention, a specialty that facilitates stroke treatment ...
(Date:7/29/2014)... HILL, Conn. , July 29, 2014 Numotion,s ... 2014, Mike Swinford will be the company,s new ... a highly successful 22-year career at GE where he worked ... million in annual revenue to over $5 billion. His most ... Global Services. "I am thrilled to join ...
(Date:7/29/2014)... Fla. , July 29, 2014 /PRNewswire-iReach/ -- ... service provider, has launched its Medical Equipment ...  These services are tailored to the cruise ... standards prompted industry operators to propose that they ... MHG Medical,s new program is intended to create ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Numotion Names Mike Swinford CEO 2MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2
... NHS National Innovation Centre supports the cost ... Medical announced today the findings of an independent economic ... Innovation Centre, the NHS organization which supports innovators, commissioners, ... of innovations that will benefit the NHS. ...
... --  Janet R. Dees, CEO/President of American Vascular Access, ... newest vascular access center in Columbus, Georgia.  "Our Newnan, ... Vascular Access, LLC., and the addition of the Columbus, ... "Our goal has continued to be to ...
Cached Medicine Technology:NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually 2American Vascular Access Continues Growth in Georgia 2
(Date:7/30/2014)... NY (PRWEB) July 30, 2014 Running ... Dr Steven Shoshany aims to help runners keep ... techniques to help athletes continue training. He has recently ... ART (Active Release Techniques), Cold Laser Therapy, Graston technique ... injury free. , Dr Shoshany often combines ...
(Date:7/30/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on snacks . , Dancing ... are recalled because they contain organic Carob ... salmonella. Salmonella can cause serious, fatal infections in people ... cause abdominal pain, vomiting, nausea, diarrhea, or fever. In ...
(Date:7/30/2014)... The Diabetes Daily Grind had its ... and Ryan Fightmaster hope to gain attention for the ... July 26th of this year, Clour and Fightmaster started ... the diabetic life. By sharing stories on their ... believe other diabetics will find ways to live with ...
(Date:7/30/2014)... July 30, 2014 An interesting fact ... community where motorcycle enthusiasts congregate, BikerKiss.com . The ... that were revealed by BikerKiss indicate that women motorcycle ... past 3 years. , Members on BikerKiss are mostly ... Australia and some other European countries who are there ...
(Date:7/30/2014)... 30, 2014 According to the Nasal Polyps ... a comprehensive guide that teaches people how to cure their ... book uncovers to readers the horrible truth about conventional treatments ... that inside this book, people will learn how to prevent ... asthma, and nasal infections. , Nasal Polyps Treatment Miracle, as ...
Breaking Medicine News(10 mins):Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2Health News:Single Women Motorcycle Riders In Rapid Increase 2Health News:Nasal Polyps Treatment Miracle Book Review Exposes Manuel Richards' Guide For Treating Nasal Polyps – Vkool.com 2Health News:Nasal Polyps Treatment Miracle Book Review Exposes Manuel Richards' Guide For Treating Nasal Polyps – Vkool.com 3
... ... ... ... HOUSTON , March 1 Despite Northstar management,s recent claim ...
... ... on Executive Position , ... Tucson, Ariz. (Vocus) February 28, 2010 -- Tom Rios has been promoted to ... Most recently, he had been Splendido’s director of accounting., , ,Rios will work with ...
... ... ... ... ...
... ... ... ... , , ...
... ... ... ... ...
... Researchers from The University of Texas M. D. Anderson ... measure the severity of symptoms that can complicate stem ... graft-versus-host disease (cGVHD), and was presented with supporting research ... cGVHD - a chronic disease that requires ...
Cached Medicine News:Health News:Northstar Management Forecasts a Loss of $1.2 Million for 2010 at Its Palladium for Surgery -- Houston, Ltd. Centre 2Health News:Tom Rios Named Executive Director at Splendido 2Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 2Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 3Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 4Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 5Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 6Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 7Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 2Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 3Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 4Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 2Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 3Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 4Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 5Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 2Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: